VPipe: an Automated Bioinformatics Platform for Assembly and Management of Viral Next-Generation Sequencing Data-Reference-Cited by-同舟云学术

VPipe: an Automated Bioinformatics Platform for Assembly and Management of Viral Next-Generation Sequencing Data

Published:2022-04-27 Issue:2 Volume:10 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Wagner Darlene D.¹^ORCID,Marine Rachel L.²^ORCID,Ramos Edward³^ORCID,Ng Terry Fei Fan²^ORCID,Castro Christina J.⁴^ORCID,Okomo-Adhiambo Margaret⁵^ORCID,Harvey Krysten⁴,Doho Gregory³,Kelly Reagan³^ORCID,Jain Yatish³^ORCID,Tatusov Roman L.¹³,Silva Hideky³^ORCID,Rota Paul A.²^ORCID,Khan Agha N.⁵,Oberste M. Steven²

Affiliation:

1. Eagle Global Scientific LLC, Atlanta, Georgia, USA

2. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

3. General Dynamics Information Technology, Atlanta, Georgia, USA

4. Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee, USA

5. Office of Informatics, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Abstract

Computational infrastructure and bioinformatics analysis are bottlenecks in the application of NGS to viral pathogens. As of September 2021, VPipe has been used by the U.S.

Funder

HHS | Centers for Disease Control and Prevention

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.02564-21

Reference48 articles.

1. Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory

2. Next Generation Sequencing and Bioinformatics Methodologies for Infectious Disease Research and Public Health: Approaches, Applications, and Considerations for Development of Laboratory Capacity

3. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation